Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Malignant Melanoma

Free Subscription 23.01.2023 3 Am J Dermatopathol 1 Am J Ophthalmol 3 Ann Surg Oncol 1 BMC Ophthalmol 5 J Am Acad Dermatol 3 J Clin Oncol 1 Melanoma Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. HARTZELL C, Hernandez E, Arriola AGP
   A Rare Collison of Vulvar Melanoma and Extramammary Paget Disease: Case Report and Review of the Literature.
   Am J Dermatopathol. 2023;45:133-136.
   PubMed        
   
   
2. DONATI M, Steiner P, Kazakov DV
   BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature.
   Am J Dermatopathol. 2023;45:117-122.
   PubMed         Abstract available
   
   
3. MATA DA, Lian CG, Hafeez F
   Determining the Association Between Melanomas and Fields of Melanocytic Dysplasia.
   Am J Dermatopathol. 2023;45:90-92.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

4. LIEGL R, Schmelter V, Fuerweger C, Ehret F, et al
   Robotic CyberKnife Radiosurgery for the Treatment of Choroidal and Ciliary Body Melanoma.
   Am J Ophthalmol. 2023 Jan 12:S0002-9394(22)00519.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

5. SHARON CE, Tortorello GN, Gimotty PA, Beasley GM, et al
   Outcomes of Single Node Excision Compared with Lymph Node Dissection for Patients with Clinical Stage III N1b Cutaneous Melanoma.
   Ann Surg Oncol. 2023 Jan 16. doi: 10.1245/s10434-022-12999.
   PubMed        
   
   
6. JEREMIASSE B, van Scheltinga CEJT, Smeele LE, Tolboom N, et al
   Sentinel Lymph Node Procedure in Pediatric Patients with Melanoma, Squamous Cell Carcinoma, or Sarcoma Using Near-Infrared Fluorescence Imaging with Indocyanine Green: A Feasibility Trial.
   Ann Surg Oncol. 2023 Jan 15. doi: 10.1245/s10434-022-12978.
   PubMed         Abstract available
   
   
7. RHODIN KE, Farrow NE, Xu M, Lee J, et al
   National Trends in Management of Pathologic Stage III Melanoma.
   Ann Surg Oncol. 2023 Jan 15. doi: 10.1245/s10434-023-13101.
   PubMed        
   
   

   
   BMC Ophthalmol

8. SIMPSON A, Mamalis N, Gee C, Harrie RP, et al
   Large ciliary body melanocytoma with pseudocysts: a case report.
   BMC Ophthalmol. 2023;23:24.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

9. LEE K
   JAAD Game Changers: Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.
   J Am Acad Dermatol. 2023;88:517.
   PubMed        
   
   
10. NAVARRETE-DECHENT C, Cordova M, Aleissa S, Liopyris K, et al
    Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study.
    J Am Acad Dermatol. 2023;88:371-379.
    PubMed         Abstract available
    
    
11. WILSON BN, Shah R, Musthaq S, Vaidya T, et al
    Development of patient decision aids for the treatment of lentigo maligna and low-risk basal cell carcinoma.
    J Am Acad Dermatol. 2023;88:440-442.
    PubMed        
    
    
12. OH BH, Lee S, Park JW, Lee JY, et al
    Risk of recurrence of nail unit melanoma after functional surgery versus amputation.
    J Am Acad Dermatol. 2023 Jan 12:S0190-9622(23)00063.
    PubMed         Abstract available
    
    
13. BEAL BT, Udkoff J, Aizman L, Etzkorn J, et al
    Outcomes of invasive melanoma of the head and neck treated with Mohs Micrographic Surgery - a multicenter study.
    J Am Acad Dermatol. 2023 Jan 12:S0190-9622(23)00062.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

14. KIRKWOOD JM, Strawderman MH, Ernstoff MS, Smith TJ, et al
    Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.
    J Clin Oncol. 2023;41:425-435.
    PubMed         Abstract available
    
    
15. SCHWARTZ GK
    Flashback Foreword: Adjuvant Interferon alpha-2b for High-Risk Melanoma.
    J Clin Oncol. 2023;41:423-424.
    PubMed        
    
    
16. BOUFFET E, Geoerger B, Moertel C, Whitlock JA, et al
    Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade Glioma.
    J Clin Oncol. 2022 Nov 14:JCO2201000. doi: 10.1200/JCO.22.01000.
    PubMed         Abstract available
    
    

    
    Melanoma Res

17. PINTO C, Aluai-Cunha C, Santos A
    The human and animals' malignant melanoma: comparative tumor models and the role of microbiome in dogs and humans.
    Melanoma Res. 2023 Jan 20:CMR.0000000000000880.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: